[go: up one dir, main page]

NO992010D0 - New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes - Google Patents

New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes

Info

Publication number
NO992010D0
NO992010D0 NO992010A NO992010A NO992010D0 NO 992010 D0 NO992010 D0 NO 992010D0 NO 992010 A NO992010 A NO 992010A NO 992010 A NO992010 A NO 992010A NO 992010 D0 NO992010 D0 NO 992010D0
Authority
NO
Norway
Prior art keywords
syndromes
estrogen
prevention
treatment
related diseases
Prior art date
Application number
NO992010A
Other languages
Norwegian (no)
Other versions
NO992010L (en
Inventor
Poul Jacobsen
Svend Treppendahl
Paul Stanley Bury
Anders Kanstrup
Lise Brown Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO992010D0 publication Critical patent/NO992010D0/en
Publication of NO992010L publication Critical patent/NO992010L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO992010A 1996-10-28 1999-04-27 New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes NO992010L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK120096 1996-10-28
PCT/DK1997/000480 WO1998018773A1 (en) 1996-10-28 1997-10-28 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Publications (2)

Publication Number Publication Date
NO992010D0 true NO992010D0 (en) 1999-04-27
NO992010L NO992010L (en) 1999-06-25

Family

ID=8102107

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992010A NO992010L (en) 1996-10-28 1999-04-27 New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes

Country Status (8)

Country Link
EP (1) EP0937058A1 (en)
JP (1) JP2001502705A (en)
AU (1) AU4700097A (en)
CA (1) CA2270113A1 (en)
IL (1) IL129622A0 (en)
NO (1) NO992010L (en)
WO (1) WO1998018773A1 (en)
ZA (1) ZA979642B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356986A1 (en) * 1998-12-30 2000-07-06 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
JP4913056B2 (en) * 2004-09-21 2012-04-11 マーシャル エドワーズ，インコーポレーテッド Substituted chroman derivatives, pharmaceuticals, and therapeutic uses
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP1794141B1 (en) 2004-09-21 2011-11-09 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
WO2006032086A1 (en) * 2004-09-21 2006-03-30 Novogen Research Pty Ltd Chroman derivatives, medicaments and use in therapy
US9708283B2 (en) 2010-11-01 2017-07-18 Mei Pharma, Inc. Isoflavonoid compositions and methods for the treatment of cancer
SI2953938T1 (en) * 2014-02-07 2018-01-31 Novogen Ltd. Functionalised benzopyran compounds and use thereof
CN116139125A (en) 2015-02-02 2023-05-23 梅制药公司 combination therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1543749A1 (en) * 1966-02-16 1969-12-11 Merck Ag E Process for the preparation of 3,4-cis-4-aryl-isoflavans
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) * 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Also Published As

Publication number Publication date
CA2270113A1 (en) 1998-05-07
IL129622A0 (en) 2000-02-29
AU4700097A (en) 1998-05-22
JP2001502705A (en) 2001-02-27
EP0937058A1 (en) 1999-08-25
ZA979642B (en) 1998-04-28
NO992010L (en) 1999-06-25
WO1998018773A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
NO944857D0 (en) Fluorenyl-containing metallocenes, process for their preparation and process for polymerization of olefins using the metallocenes
NO954942L (en) New erythromycin derivatives, processes for their preparation and use of the derivatives as drugs
NL1001338A1 (en) 2-Hydroxyphenyltriazines, process for their preparation and use of UV absorbers.
NO900613D0 (en) PROCEDURE FOR THE PREPARATION OF ACTIVATED CHITOSANES AND USE IN THE PREPARATION OF CHITOSANDER DERIVATIVES.
FI921260A0 (en) PROCEDURE FOR THE PROCESSING OF PROFILES.
EE9700044A (en) Heteroaryloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds.
TR199500952A2 (en) New n-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effect.
DE69715482D1 (en) Preparation of 1,1,1,3,3-pentachlorobutane and 1,1,1,3,3-pentafluorobutane
EE03242B1 (en) Method of continuous boiling of must, method of making beer from this must and beer produced by this method
DK0630600T3 (en) Bed or sleeping area that can be pulled into the ceiling
NO911956L (en) PROCEDURE FOR THE PREPARATION OF OXYDANT SENSITIVE AND INSENSITIVE, AROMATIC ESTERS AS HUMAN NEUTROPHIL ELASTASE INHIBITORS
NO992010D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO995723L (en) New triptolide derivatives useful in the treatment of autoimmune diseases
NO308469B1 (en) Triazine-containing anionic compounds suitable as antiviral compounds, use of the compounds and pharmaceutical composition
NO992009D0 (en) New trans-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992005D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO171484C (en) APPLICATION OF SUGARCARCOOL, POLYOXYLYCYLENETS OR ETHMONOSACCHARIDE OR MIXTURES THEREOF BASED FOR SOMATOSTATINES AND CALCITONINES FOR AA INCREASED BIOTAILABILITY OF THE PEPTIDES ORAL OR RECTAL.
NO992008D0 (en) New (+) enantiomers of cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO995722D0 (en) New triptolide derivatives useful in the treatment of autoimmune diseases
MX22991A (en) SWEETENING AGENT DERIVED FROM L-ASPARTIC OR L-GLUTAMIC ACID AND THE PROCEDURE FOR ITS PREPARATION.
NO992003L (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992002D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO953989L (en) New polycyclic systems and derivatives thereof, such as neurotransmitter release assays useful in the treatment of recognition disorders
NO992004D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes
NO992006D0 (en) New cis-3,4-chromane derivatives that can be used in the prevention or treatment of ° estrogen-related diseases or syndromes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application